Angiogenesis, the process of new capillary development, is normallycontrolled, limited, and dependent on a balance between stimulatoryand inhibitory factors. In men, wound healing is the only physiologicexample of this process after birth, whereas in women angiogenesisis also necessary for ovulation, the formation of the corpusluteum, and placental development.
Angiogenesis is an essential feature of many diseases, amongwhich are cancers, various retinopathies, rheumatoid arthritis,psoriasis, and atherosclerosis.1 In these pathologic states,the balance between stimulatory and inhibitory factors favorspersistent capillary growth. We can view Kaposi's sarcoma, withits abundant slit-like vascular spaces, proliferating spindle. . . [Full Text of this Article]
References
This article has been cited by other articles:
Malatos, S., Neubert, H., Kicman, A. T., Iles, R. K.
(2005). Identification of Placental Transforming Growth Factor-{beta} and Bikunin Metabolites as Contaminants of Pharmaceutical Human Chorionic Gonadotrophin Preparations by Proteomic Techniques. Mol. Cell. Proteomics
4: 984-992
[Abstract][Full Text]
Butler, S. A., Iles, R. K.
(2003). Ectopic Human Chorionic Gonadotropin {beta} Secretion by Epithelial Tumors and Human Chorionic Gonadotropin {beta}-Induced Apoptosis in Kaposi's Sarcoma: Is There a Connection?. Clin. Cancer Res.
9: 4666-4673
[Abstract][Full Text]
Antman, K., Chang, Y.
(2000). Kaposi's Sarcoma. NEJM
342: 1027-1038
[Full Text]
Harris, P. J., Russo, I. H., Grulich, A. E., Kaldor, J. M., Gill, P. S., Lunardi-Iskandar, Y., Gallo, R. C., Krown, S. E., Rabkin, C. S.
(1997). Intralesional Human Chorionic Gonadotropin for Kaposi's Sarcoma. NEJM
336: 1187-1189
[Full Text]